Literature DB >> 20521183

Cognitive profile of children with neurofibromatosis and reading disabilities.

Laurie E Cutting1, Terry M Levine.   

Abstract

A large percentage of children with Neurofibromatosis Type 1(NF-1) have learning disabilities, often in the realm of reading. Previous studies have indicated that children with NF-1 show a neuropsychological profile similar to idiopathic reading disabilities (IRD); however, studies typically have not subdivided children with NF-1 into those who do and do not have RD (NF+RD and NFnoRD, respectively). The current study examined the cognitive profile of children with NF-1 with and without RD and compared them to children with IRD as well as to typically developing readers (Controls). Findings showed that children with NF+RD performed similarly to children with IRD on phonological, rapid naming, and reading comprehension measures; however, children with NF+RD displayed pronounced visual-spatial deficits as compared to IRD and Control groups. In addition, when comparing the NF-1 groups to each other as well as to the control and IRD groups, the current study reported that there were no oral language differences; lack of findings in the realm of oral language was attributed to the fact that groups were equated on IQ. Overall, findings suggest that a more refined classification of children with NF-1 may be helpful for tailoring academic interventions.

Entities:  

Mesh:

Year:  2010        PMID: 20521183      PMCID: PMC2929318          DOI: 10.1080/09297041003761985

Source DB:  PubMed          Journal:  Child Neuropsychol        ISSN: 0929-7049            Impact factor:   2.500


  24 in total

Review 1.  The visual deficit theory of developmental dyslexia.

Authors:  G F Eden; J W VanMeter; J M Rumsey; T A Zeffiro
Journal:  Neuroimage       Date:  1996-12       Impact factor: 6.556

Review 2.  Cognitive profile of neurofibromatosis type 1.

Authors:  Terry M Levine; April Materek; Jessica Abel; Madeline O'Donnell; Laurie E Cutting
Journal:  Semin Pediatr Neurol       Date:  2006-03       Impact factor: 1.636

3.  The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder.

Authors:  C W Koth; L E Cutting; M B Denckla
Journal:  Child Neuropsychol       Date:  2000-09       Impact factor: 2.500

4.  Treatment of ADHD in neurofibromatosis type 1.

Authors:  Victor-F Mautner; Lan Kluwe; Sarang D Thakker; Robert A Leark
Journal:  Dev Med Child Neurol       Date:  2002-03       Impact factor: 5.449

Review 5.  Neurocognitive dysfunction in children with neurofibromatosis type 1.

Authors:  Tena L Rosser; Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

6.  Visual-spatial performance deficits in children with neurofibromatosis type-1.

Authors:  Gregory W Schrimsher; Rebecca L Billingsley; John M Slopis; Bartlett D Moore
Journal:  Am J Med Genet A       Date:  2003-07-30       Impact factor: 2.802

7.  Impact of neurofibromatosis type 1 on school performance.

Authors:  Lianne C Krab; Femke K Aarsen; Arja de Goede-Bolder; Coriene E Catsman-Berrevoets; Willem F Arts; Henriette A Moll; Ype Elgersma
Journal:  J Child Neurol       Date:  2008-09       Impact factor: 1.987

Review 8.  Potential influences on mathematical difficulties in children and adolescents with neurofibromatosis, type 1.

Authors:  Bartlett D Moore
Journal:  Dev Disabil Res Rev       Date:  2009

9.  Children and adolescents with neurofibromatosis 1: a behavioral phenotype.

Authors:  C V Dilts; J C Carey; J C Kircher; R O Hoffman; D Creel; K Ward; E Clark; C O Leonard
Journal:  J Dev Behav Pediatr       Date:  1996-08       Impact factor: 2.225

10.  Neuropsychological profile of children with neurofibromatosis, brain tumor, or both.

Authors:  B D Moore; J L Ater; M N Needle; J Slopis; D R Copeland
Journal:  J Child Neurol       Date:  1994-10       Impact factor: 1.987

View more
  9 in total

1.  Teaching reading to children with neurofibromatosis type 1: a clinical trial with random assignment to different approaches.

Authors:  Laura A Barquero; Angela M Sefcik; Laurie E Cutting; Sheryl L Rimrodt
Journal:  Dev Med Child Neurol       Date:  2015-04-22       Impact factor: 5.449

2.  Absence of exon 17 c.2970-2872delAAT mutation in Turkish NF1 patients with mild phenotype.

Authors:  Yunus Kasim Terzi; Burcu Sirin; Esra Serdaroglu; Banu Anlar; Sabiha Aysun; Guzen Hosgor; Elif Acar Arslan; Sukriye Ayter
Journal:  Childs Nerv Syst       Date:  2011-07-06       Impact factor: 1.475

Review 3.  The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.

Authors:  Maria T Acosta; Carrie E Bearden; F Xavier Castellanos; Xavier F Castellanos; Laurie Cutting; Ype Elgersma; Gerard Gioia; David H Gutmann; Yong-Seok Lee; Eric Legius; Maximillian Muenke; Kathryn North; Luis F Parada; Nancy Ratner; Kim Hunter-Schaedle; Alcino J Silva
Journal:  Am J Med Genet A       Date:  2012-07-20       Impact factor: 2.802

4.  Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.

Authors:  Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta
Journal:  Behav Genet       Date:  2020-02-05       Impact factor: 2.805

5.  Educational delay and attainment in persons with neurofibromatosis 1 in Denmark.

Authors:  Karoline Doser; Line Kenborg; Elisabeth Wreford Andersen; Pernille Envold Bidstrup; Anja Kroyer; Hanne Hove; John Østergaard; Sven Asger Sørensen; Christoffer Johansen; John Mulvihill; Jeanette Falck Winther; Susanne Oksbjerg Dalton
Journal:  Eur J Hum Genet       Date:  2019-02-28       Impact factor: 4.246

Review 6.  A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.

Authors:  Andrew J D Crow; Jennica M Janssen; Carolina Marshall; Anne Moffit; Laura Brennan; Christian G Kohler; David R Roalf; Paul J Moberg
Journal:  Am J Med Genet A       Date:  2022-05-12       Impact factor: 2.578

Review 7.  An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains.

Authors:  Taylor F Smith; Jessica A Kaczorowski; Maria T Acosta
Journal:  Childs Nerv Syst       Date:  2020-07-03       Impact factor: 1.475

Review 8.  Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.

Authors:  Jody F Longo; Shannon M Weber; Brittany P Turner-Ivey; Steven L Carroll
Journal:  Adv Anat Pathol       Date:  2018-09       Impact factor: 4.571

9.  Brain Tumors in NF1 Children: Influence on Neurocognitive and Behavioral Outcome.

Authors:  Matilde Taddei; Alessandra Erbetta; Silvia Esposito; Veronica Saletti; Sara Bulgheroni; Daria Riva
Journal:  Cancers (Basel)       Date:  2019-11-11       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.